Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

Cancer treatments ... antibodies against tumor antigens, checkpoint inhibitors that block tumors from accessing suppressive proteins on immune cells, and chimeric antigen receptor (CAR) T cells ...

Targeting clonal antigens and circumventing dysfunctional states may be important for conferring clinical responses to TIL therapy.

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor cells are easily recognizable by the immune system. In addition, they are ...

The new test looks for a specific type ... up about half of all skin cancer sufferers -- determined that approximately 80% of those who had evidence of circulating tumor DNA, or ctDNA, in their ...

Cryptic peptides, which are expressed in pancreatic cancer cells ... of T cells to recognize a specific peptide, or antigen, found on tumor cells. There are many efforts underway to identify ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

Affiliate Investigator, Clinical Research Division, Fred Hutch Affiliate Investigator Clinical Research Division, Fred Hutch The Veatch lab studies tumor antigen specific ... cancer. Dr. Veatch is a ...

Now, technological advances like rapid DNA sequencing, lymph node targeting, and AI-informed antigen ... cancer shows that Elicio’s vaccine induced 100-fold increases in tumor-specific T cells ...

Carisma Therapeutics is developing a unique, differentiated immuno-oncology (IO) treatment for solid tumors based on chimeric antigen ... ovarian cancer (SKOV3) cells, a single HER2-specific ...